Skip to main content
Fig. 3 | EJNMMI Physics

Fig. 3

From: Pharmacokinetic modeling of a novel hypoxia PET tracer [18F]HX4 in patients with non-small cell lung cancer

Fig. 3

a, b, c Averaged simplified measures at 2–2.5 h p.i. for all tumor VOI, compared to VT derived with NLR from 0–2.5 h dynamic PET data using the 2T4k+VB model and IDIF: a standardized uptake value normalized to patient weight (SUVBW), b tumor-to-blood ratio (TBr), c tumor-to-muscle ratio (TMr); d TBr as measured at 4–4.5 h p.i. compared to VT derived from 0–4.5 h dynamic PET data

Back to article page